PC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchThere is no single “PMDA approval” route for every medical device in Japan. The route depends on the device’s Japanese classification and, for some Class II and III devices, whether a certification standard applies: Class I devices are notified, qualifying Class II and III devices can be certified by a registered certification body (RCB), and the remaining Class II and III devices plus all Class IV devices require MHLW approval with PMDA review. Overseas manufacturers also need an appropriate Japan-based authorization arrangement and must address foreign manufacturing-site registration and quality-management-system (QMS) review.
What “PMDA approval” means in Japan
PMDA is Japan’s Pharmaceuticals and Medical Devices Agency. The Ministry of Health, Labour and Welfare (MHLW) and prefectural authorities also have regulatory roles. Under Japan’s PMD Act, commercial shipment of a medical device is subject to the applicable regulatory permission, registration, or approval; the term “PMDA approval” is often used loosely for several different procedures.
For a device requiring MHLW approval, PMDA conducts the product review. Other devices follow notification or RCB certification routes instead. A product authorization, registration of a foreign manufacturer or site, and the Japanese marketing authorization holder’s (MAH’s) license are separate matters, not one universal “PMDA registration.” PMDA’s English procedural guide, a provisional translation dated August 2025, says the Japanese original prevails if the two versions differ.
Which regulatory route applies?
PMDA describes four risk classes. Classification alone does not settle every route: for Class II and III, whether a certification standard applies also matters.
#1 Best Overall
| Japanese device class or condition | Route | Who handles the route | PMDA product review? |
|---|---|---|---|
| Class I | Notification | Notification is made to PMDA. | No MHLW approval review is described for this route. |
| Class II with an applicable certification standard | Certification | A registered certification body (RCB). | No PMDA product review is described for this certification route. |
| Class II without an applicable certification standard | MHLW approval | Application is submitted to PMDA for review for MHLW approval. | Yes. |
| Class III with an applicable certification standard | Certification | An RCB. | No PMDA product review is described for this certification route. |
| Class III without an applicable certification standard | MHLW approval | Application is submitted to PMDA for review for MHLW approval. | Yes. |
| Class IV | MHLW approval | Application is submitted to PMDA for review for MHLW approval. | Yes. |
These are route categories, not a substitute for classifying a particular product. The intended use, Japanese general name, and applicable standard matter. The MAH must ensure efficacy, safety, and quality on the basis of evidence before submission. PMDA says product requirements are assessed case by case and offers fee-based face-to-face consultations.
How an overseas manufacturer can approach market entry
- Confirm whether the product is regulated as a medical device or IVD. If this is uncertain, PMDA directs applicants to the competent prefectural pharmaceutical-affairs division. For a formal determination, it recommends consulting through a Japan-based MAH with the authority that has jurisdiction over the MAH, or contacting MHLW. PMDA also points software as a medical device (SaMD) questions to a dedicated consultation route.
- Determine the Japanese classification and route. Establish the relevant general name, risk class, and—if the device is Class II or III—whether a certification standard applies. That determines whether the procedure is notification, RCB certification, or MHLW approval with PMDA review.
- Set up the Japan-based authorization arrangement. A foreign manufacturer proceeds through a Japanese MAH or an appointed Japanese manufacturer, as appropriate to the procedure. The MAH has corporate accountability and quality-assurance and safety-management responsibilities; it is not merely a local mailing address.
- Arrange foreign manufacturer and site registration. Before applying, obtain manufacturer codes from MHLW for the foreign manufacturing company and each relevant manufacturing site. PMDA handles the foreign-manufacturer registration procedure. The foreign manufacturer is the applicant, but an agent—typically the related marketing authorization business—must submit on its behalf; PMDA says direct filing without an agent is not permitted. Obtaining codes alone does not complete registration.
- Prepare and submit the route-specific product filing. Class I follows notification; qualifying Class II and III devices go to an RCB for certification; devices requiring MHLW approval are submitted to PMDA for review. The evidence and forms depend on the product and route. PMDA assesses evidence for efficacy, safety, and quality in its product-review role.
- Complete the applicable QMS inspection. PMDA may conduct a document-based or on-site inspection of registered device manufacturing sites in Japan or overseas. This assesses QMS compliance and whether the site can manufacture products of adequate quality; it is distinct from review of the product’s evidence.
- Maintain the local responsibilities after market entry. PMDA’s FAQ says the Japanese MAH distributing the product in Japan submits post-marketing safety reports. Market entry therefore does not end the MAH’s safety and quality responsibilities.
What foreign applicants should plan for
Japanese-language filings
PMDA says it does not accept marketing applications in languages other than Japanese; forms related to the application must also be submitted in Japanese. Plan for translation and regulatory review as part of preparing the filing.
Rank #2
Clinical data from outside Japan
PMDA accepts and reviews clinical data from studies conducted outside Japan for medical-device marketing approval applications. That does not establish that a particular dataset is sufficient for a specific product; its relevance and adequacy should be discussed with the MAH and agency.
Product review and manufacturing-system review
Product review addresses the evidence for a device’s efficacy, safety, and quality. QMS review examines the manufacturing system and relevant site compliance. Depending on the applicable requirements, the latter may involve documents, an on-site inspection, or both; completing one assessment does not make the other a substitute.
Rank #3
- The 2024 DOT Medical Examination Guide Book provides a detailed guide to the physical standards to be qualified to drive a CMV. Medical exam handbook helps you understand medical qualification and the examination process.
- Regulation Alert. The FMCSA update to its Medical Advisory Criteria (Appendix A to Part 391) and accompanying medical guidance 1/24/24. All prior versions of medical guidance have been superseded. Certified Medical Examiners use the medical guidance but are not obligated by law to follow the guidance. No physical qualification regulatory standards in 391.41(b) have changed.
- Includes. Tabbed pages for quick and easy referencing, 100+ illustrations, handouts, and addresses the regulatory side of driver wellness. Alternative vision standard 391.44 and the Insulin-treated diabetes mellitus (ITDM) rule in 391.46.
- Variety of Topics. Purpose of exam, explanation, requirements, and guidelines for exam, Medical Registry, regulations, wellness and demands placed on commercial motor drivers, forms and recordkeeping, ADA and HIPAA info, and FAQs.
- Specifications: 5” x 7" Medical Exams Handbook, English, Spiralbound. Copyright 2024.
Classification and case-specific requirements
When classification, an applicable standard, or the filing route is uncertain, resolve that question before building the submission. The relevant prefectural authority may be involved in formal device-status determinations, while PMDA consultations can address product-specific requirements. Confirm current forms and requirements with the MAH and appropriate regulator.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Timing and cost depend on the route
There is no universal approval duration or cost established for these routes. Classification, certification-standard availability, product-specific evidence requirements, consultation needs, and applicable reviews affect the work required. Do not treat an estimate for one product or route as a general Japan market-entry timeline or fee.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
